[ad_1] Sanofi has not finished with the Dépakine case. After the health component that earned him a group action, a new chapter, environmental this time, has just opened. At issue: the Mourenx …
Read More »[ad_1] Sanofi has not finished with the Dépakine case. After the health component that earned him a group action, a new chapter, environmental this time, has just opened. At issue: the Mourenx …
Read More »